Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN)
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
2009
|
| _version_ | 1797102893526941696 |
|---|---|
| author | Maughan, T Adams, R Smith, C Seymour, M Wilson, R Meade, A Fisher, D Madi, A Cheadle, J Kaplan, R |
| author_facet | Maughan, T Adams, R Smith, C Seymour, M Wilson, R Meade, A Fisher, D Madi, A Cheadle, J Kaplan, R |
| author_sort | Maughan, T |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T06:12:17Z |
| format | Journal article |
| id | oxford-uuid:efef9966-88bf-4f9e-bdf8-b55b2d100ac1 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T06:12:17Z |
| publishDate | 2009 |
| record_format | dspace |
| spelling | oxford-uuid:efef9966-88bf-4f9e-bdf8-b55b2d100ac12022-03-27T11:43:51ZAddition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN)Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:efef9966-88bf-4f9e-bdf8-b55b2d100ac1Symplectic Elements at Oxford2009Maughan, TAdams, RSmith, CSeymour, MWilson, RMeade, AFisher, DMadi, ACheadle, JKaplan, R |
| spellingShingle | Maughan, T Adams, R Smith, C Seymour, M Wilson, R Meade, A Fisher, D Madi, A Cheadle, J Kaplan, R Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN) |
| title | Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN) |
| title_full | Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN) |
| title_fullStr | Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN) |
| title_full_unstemmed | Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN) |
| title_short | Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN) |
| title_sort | addition of cetuximab to oxaliplatin based combination chemotherapy ct in patients with kras wild type advanced colorectal cancer acrc a randomised superiority trial mrc coin |
| work_keys_str_mv | AT maughant additionofcetuximabtooxaliplatinbasedcombinationchemotherapyctinpatientswithkraswildtypeadvancedcolorectalcanceracrcarandomisedsuperioritytrialmrccoin AT adamsr additionofcetuximabtooxaliplatinbasedcombinationchemotherapyctinpatientswithkraswildtypeadvancedcolorectalcanceracrcarandomisedsuperioritytrialmrccoin AT smithc additionofcetuximabtooxaliplatinbasedcombinationchemotherapyctinpatientswithkraswildtypeadvancedcolorectalcanceracrcarandomisedsuperioritytrialmrccoin AT seymourm additionofcetuximabtooxaliplatinbasedcombinationchemotherapyctinpatientswithkraswildtypeadvancedcolorectalcanceracrcarandomisedsuperioritytrialmrccoin AT wilsonr additionofcetuximabtooxaliplatinbasedcombinationchemotherapyctinpatientswithkraswildtypeadvancedcolorectalcanceracrcarandomisedsuperioritytrialmrccoin AT meadea additionofcetuximabtooxaliplatinbasedcombinationchemotherapyctinpatientswithkraswildtypeadvancedcolorectalcanceracrcarandomisedsuperioritytrialmrccoin AT fisherd additionofcetuximabtooxaliplatinbasedcombinationchemotherapyctinpatientswithkraswildtypeadvancedcolorectalcanceracrcarandomisedsuperioritytrialmrccoin AT madia additionofcetuximabtooxaliplatinbasedcombinationchemotherapyctinpatientswithkraswildtypeadvancedcolorectalcanceracrcarandomisedsuperioritytrialmrccoin AT cheadlej additionofcetuximabtooxaliplatinbasedcombinationchemotherapyctinpatientswithkraswildtypeadvancedcolorectalcanceracrcarandomisedsuperioritytrialmrccoin AT kaplanr additionofcetuximabtooxaliplatinbasedcombinationchemotherapyctinpatientswithkraswildtypeadvancedcolorectalcanceracrcarandomisedsuperioritytrialmrccoin |